Journal List > Korean J Gastroenterol > v.59(4) > 1006945

TOOLS
Shim: Does Low Dose Aspirin Increase Gastrointestinal Bleeding?
Research Update
The Korean Journal of Gastroenterology

The Korean Journal of Gastroenterology 2012; 59(4): 324-325.

Published online: 23 April 2012

DOI: https://doi.org/10.4166/kjg.2012.59.4.324

Does Low Dose Aspirin Increase Gastrointestinal Bleeding?

Ki-Nam Shim

Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.

Correspondence to: Ki-Nam Shim, Department of Internal Medicine, Ewha Medical Research Institute, Ewha Womans University School of Medicine, 911-1, Mokdong, Yangcheon-gu, Seoul 158-710, Korea. Tel: +82-2-2560-2632, Fax: +82-2-2655-2076, shimkn@ewha.ac.kr

Copyright © 2012 The Korean Society of Gastroenterology

(open-access):

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Notes

Financial support: None.

Conflict of interest: None.

References

1. Lanas A, Wu P, Medin J, Mills EJ. Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol. 2011. 9:762–768.
2. Hawkey CJ. Non-steroidal anti-inflammatory drug gastropathy: causes and treatment. Scand J Gastroenterol Suppl. 1996. 220:124–127.
3. Cutlip DE, Baim DS, Ho KK, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation. 2001. 103:1967–1971.
4. Dickinson JP, Prentice CR. Aspirin: benefit and risk in thromboprophylaxis. QJM. 1998. 91:523–538.
5. Baigent C, Blackwell L, Collins R, et al. Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009. 373:1849–1860.
6. Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. 2011. 377:31–41.
7. García Rodríguez LA, Hernández-Díaz S, de Abajo FJ. Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol. 2001. 52:563–571.
8. Lee HL, Han DS, Kim JB, et al. Gastroduodenal injury in patients with low-dose enteric coated aspirin treatment. Korean J Gastroenterol. 2003. 42:190–194.
9. Bhatt DL, Scheiman J, Abraham NS, et al. American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008. 52:1502–1517.
10. McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006. 119:624–638.
11. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006. 354:1706–1717.
12. Bae SE, Kim SE, Jung SA, et al. The effect of aspirin alone or aspirin plus additional antiplatelets therapy on upper gastrointestinal hemorrhage. Korean J Gastroenterol. 2011. 57:213–220.
TOOLS
Similar articles